When Is the Best Time to Take Victoza®?
You must take Victoza® every day as recommended by your healthcare professional, so it is best to take it at a time that you will remember to take it. The important thing is to get into a routine and take Victoza® once a day, with or without food. You do not have to adjust your dose based on what you eat or how active you are.
What Do I Need to Know About the Victoza® Pen?
Your healthcare provider must teach you how to inject Victoza® before you use it for the first time. If you have questions or do not understand the instructions, talk to your healthcare provider or pharmacist.
- Pen needles are sold separately and may require a prescription in some states. Ask your healthcare provider which needle size is best for you
- The needle recommended for use with the Victoza® Pen (32-gauge Tip) is the thinnest Pen needle from Novo Nordisk available in the US
- The majority of people studied using a 32-gauge Tip needle experienced little or no pain*
- When starting to use a new prefilled Victoza® Pen, you must follow the “First-Time Use for Each New Pen” instructions that come with it. You only need to do this 1 time with each new Pen. You should also follow these instructions if you drop your Pen. If you follow the “First Time Use for Each New Pen” instructions before each injection, however, you will run out of medication too soon
Learn how to prepare for your first injection
Support is a phone call away
VictozaCare™ Coaches and trained diabetes educators, nurses, and dieticians provide Pen training support, answer questions about Victoza®, and offer tips to help manage type 2 diabetes.
SIGN UP NOW
Or contact a VictozaCare™ Coach at 1-877-905-1126, Monday through Friday.
*Multicenter, randomized, open-label, 2-period, crossover trial in insulin-treated patients with diabetes (type 1 or type 2). Patients were randomized to self-administer insulin injections with one needle type followed by the alternative, each for 7-14 days. The 2 needle types used were NovoFine® 32-gauge Tip x 6 mm and NovoFine® 30-gauge Tip x 8 mm.
Indications and Usage
Victoza® (liraglutide [rDNA origin] injection) is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes when used along with diet and exercise.
Victoza® is not recommended as the first medication to treat diabetes. Victoza® has not been studied in patients with history of inflammation of the pancreas (pancreatitis). Victoza® is not a substitute for insulin and has not been studied in combination with prandial (mealtime) insulin. Victoza® is not for people with type 1 diabetes or people with diabetic ketoacidosis. It is not known if Victoza® is safe and effective in children. Victoza® is not recommended for use in children.
Important Safety Information
In animal studies, Victoza® caused thyroid tumors—including thyroid cancer—in some rats and mice. It is not known whether Victoza® causes thyroid tumors or a type of thyroid cancer called medullary thyroid cancer (MTC) in people, which may be fatal if not detected and treated early. Do not use Victoza® if you or any of your family members have a history of MTC or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). While taking Victoza®, tell your doctor if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Do not use Victoza® if you are allergic to liraglutide or any of the ingredients in Victoza®. Serious allergic reactions can happen with Victoza®. If symptoms of serious allergic reactions occur, stop taking Victoza® and seek medical attention. Pancreatitis may be severe and lead to death. Before taking Victoza®, tell your doctor if you have had pancreatitis, gallstones, a history of alcoholism, or high blood triglyceride levels since these medical conditions make you more likely to get pancreatitis.
Stop taking Victoza® and call your doctor right away if you have pain in your stomach area that is severe and will not go away, occurs with or without vomiting, or is felt going from your stomach area through to your back. These may be symptoms of pancreatitis.
Before using Victoza®, tell your doctor about all the medicines you take, especially sulfonylurea medicines or insulin, as taking them with Victoza® may affect how each medicine works. If you use Victoza® with insulin, you may give both injections in the same body area (for example, your stomach area), but not right next to each other.
Also tell your doctor if you have severe stomach problems such as slowed emptying of your stomach (gastroparesis) or problems with digesting food; have or have had kidney or liver problems; have any other medical conditions; or are pregnant or plan to become pregnant. Tell your doctor if you are breastfeeding or plan to breastfeed. It is unknown if Victoza® will harm your unborn baby or if Victoza® passes into your breast milk.
Your risk for getting hypoglycemia, or low blood sugar, is higher if you take Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. The dose of your sulfonylurea medicine or insulin may need to be lowered while taking Victoza®.
Victoza® may cause nausea, vomiting, or diarrhea leading to dehydration, which may cause kidney failure. This can happen in people who have never had kidney problems before. Drinking plenty of fluids may reduce your chance of dehydration.
The most common side effects with Victoza® include headache, nausea, and diarrhea. Nausea is most common when first starting Victoza®, but decreases over time in most people. Immune system related reactions, including hives, were more common in people treated with Victoza® compared to people treated with other diabetes drugs in medical studies.
Please click here for Prescribing Information and Medication Guide.
Novo Nordisk provides patient assistance for those who qualify.
Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call 1-800-FDA-1088.